Simvastatin in the Prevention of Recurrent Pancreatitis: Design and Rationale of a Multicenter Triple-Blind Randomized Controlled Trial, the SIMBA Trial

Overview of attention for article published in Frontiers in Medicine, February 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 11 X users

Readers on

mendeley: 14 Mendeley

Summary X

So far, Altmetric has seen 15 X posts from 11 X users, with an upper bound of 52,172 followers.

RT @aegastro: Aquí tenéis el link del protocolo del EECC publicado: https://t.co/oJkNrY99rD

25 Sep 2023

Reply Repost Favourite

Aquí tenéis el link del protocolo del EECC publicado: https://t.co/oJkNrY99rD

04 Jun 2023

Reply Repost Favourite

@CrazyRxMan Simba trial is based on this! https://t.co/SyXfolOgvf

05 Jun 2021

Reply Repost Favourite

New Research: Simvastatin in the Prevention of Recurrent Pancreatitis: Design and Rationale of a Multicenter Triple-Blind Randomized Controlled Trial, the SIMBA Trial: Background: One in every four patients with a first… https://t.co/7Tc5HydMMr #medicalcar

13 Feb 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.